Baxter, CSI, and LivaNova share their MLR modernization, best practices for compliance, and pitfalls to avoid.
For any medtech organization, the medical, legal, regulatory (MLR) review and approval of promotional materials is crucial for communication with stakeholders, including HCPs, patients, regulators, shareholders, and research partners.
MLR systems, however, can be complex and overwhelming, increasing the risk of noncompliant communications reaching the public.
Complete the form to hear from leaders at Baxter, Cardiovascular Systems, Inc. (CSI), and LivaNova about their MLR experiences during Veeva MedTech Summit.
You'll learn:
- The organizational challenges that led panelists to overhaul existing review processes.
- Three best practice approaches to stay ahead of review issues and avoid problems.
- How to drive successful implementation through engagement, execution, and executive sponsorship.